关注我国男性乳腺癌的诊治

To strengthen the diagnosis and treatment of male breast cancer in China

男性乳腺癌占所有乳腺癌患者的比例在欧美国家约1．0％，在我国约为1．4％，但在我国部分地区达2．9％（1．9％～6．5％）。当前在我国，由于该病尚未引起医患重视，存在漏诊、误诊及治疗延误情况，影响了患者的预后。因此，应加强对男性乳腺癌相关知识的普及，对其进行正确的诊断和治疗。

Male breast cancer is a rare disease with an incidence of about 1% of breast cancers in USA, and about 1.4% in China. Male breast cancer accounts for 1.9% to 6.5%（with the mean value of 2.9%） of breast cancers in southwest of China. In China, male breast cancer is usually with poor prognosis caused by delayed diagnosis and treatment, because of being ignored by the community. It is important to strengthen the popular science propaganda, diagnosis and treatment of male breast cancer in China.